From Protocol to Publication: Reducing Costs and Maximizing Efficiency for Investigator-Initiated Trials

Dr. Harsha Rajasimha, Founder and CEO of Jeeva Informatics, highlights the importance and value of Investigator-Initiated Trials (IITs) in gathering real-world data on the efficacy, alternate uses, treatment comparisons, and cost-effectiveness of licensed drugs. Led by non-pharmaceutical...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: TRI Source Type: news